课题基金 / 基金详情

Mucosal Associated Invariant T-cells (MAIT cells) as Key Mediators of Anti-Tumor Immune Responses and the Microbiome Effect in Non-Small Cell Lung Cancer (NSCLC)

Mucosal Associated Invariant T-cells (MAIT cells) as Key Mediators of Anti-Tumor Immune Responses and the Microbiome Effect in Non-Small Cell Lung Cancer (NSCLC)
粘膜相关不变 T 细胞 (MAIT 细胞) 作为非小细胞肺癌 (NSCLC) 抗肿瘤免疫反应和微生物组效应的关键介质
批准号：
409612
负责人：
Sacher Adrian G
金额：
$20.62万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=409612&lang=en
关键词：
Immunotherapy Microbiome Non-Small Cell Lung Cancer Tumor Immunology

项目摘要

项目成果

Sacher Adrian G的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The treatment of lung cancer has been recently revolutionized by the development of immunotherapies such as PD1 inhibitors. However, attempts to develop improved immunotherapies have been hampered by a limited understanding of the immune cell populations
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantitative Plasma Genotyping as a Biomarker of Treatment Response in Advanced NSCLC
  • 批准号：
    318940
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $4.37万
  • 财政年份：
    2014
  • 负责人：
    Sacher Adrian G
  • 依托单位：
    Dana-Farber Cancer Institute (Boston)
Translating targeted next-generation sequencing into a clinical tool for personalized management of squamous cell lung cancer
  • 批准号：
    302457
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $0.0万
  • 财政年份：
    2013
  • 负责人：
    Sacher Adrian G
  • 依托单位：
    Dana-Farber Cancer Institute (Boston)
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis